Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

  1. Ferreiro-Pantín, M.
  2. Anido-Herranz, U.
  3. Betancor, Y.Z.
  4. Cebey-López, V.
  5. León-Mateos, L.
  6. García-González, J.
  7. García-Acuña, S.M.
  8. Fernández-Díaz, N.
  9. Tubio, J.M.C.
  10. López-López, R.
  11. Ruiz-Bañobre, J.
Revista:
ESMO Open

ISSN: 2059-7029

Ano de publicación: 2023

Volume: 8

Número: 4

Tipo: Artigo

DOI: 10.1016/J.ESMOOP.2023.101611 GOOGLE SCHOLAR lock_openAcceso aberto editor